Similar articles

• Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.

  Weckermann D, Goppelt M, Dorn R, Wawroschek F, Harzmann R. Weckermann D, et al. BJU Int. 2006 Jun;97(6):1173-8. doi: 10.1111/j.1464-410X.2006.06166.x. BJU Int. 2006. PMID: 16686707
• Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.

  Boorjian SA, Thompson RH, Siddiqui S, Bagniewski S, Bergstralh EJ, Karnes RJ, Frank I, Blute ML. Boorjian SA, et al. J Urol. 2007 Sep;178(3 Pt 1):864-70; discussion 870-1. doi: 10.1016/j.juro.2007.05.048. Epub 2007 Jul 16. J Urol. 2007. PMID: 17631342
• Is radiotherapy useful in node-positive prostate cancer patients after radical prostatectomy?

  Van Poppel H. Van Poppel H. Eur Urol. 2009 May;55(5):1012-3. doi: 10.1016/j.eururo.2009.02.015. Epub 2009 Feb 21. Eur Urol. 2009. PMID: 19261377 No abstract available.
• Lymph node assessment and lymphadenectomy in prostate cancer.

  Ordon M, Nam RK. Ordon M, et al. J Surg Oncol. 2009 Mar 15;99(4):215-24. doi: 10.1002/jso.21225. J Surg Oncol. 2009. PMID: 19170044 Review.
• Current status of lymph node-positive prostate cancer: Incidence and predictors of outcome.

  Swanson GP, Thompson IM, Basler J. Swanson GP, et al. Cancer. 2006 Aug 1;107(3):439-50. doi: 10.1002/cncr.22034. Cancer. 2006. PMID: 16795064 Review.